Related Experiment Video
Updated: Sep 26, 2025
06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
400
How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer
Melline G M Schilham, Heidi Küsters-Vandevelde1, Diederik M Somford
1Departments of Pathology.
Clinical Nuclear Medicine
|April 19, 2022
Summary
Detecting lymph node (LN) metastases in prostate cancer (PCa) is crucial for staging. Molecular imaging offers a new way to enhance pathological assessment of surgical specimens, improving accuracy in identifying LN metastases.
Area of Science:
- Oncology
- Pathology
- Molecular Imaging
Background:
- Accurate staging of prostate cancer (PCa) relies on detecting lymph node (LN) metastases.
- Current histopathological examination of pelvic LNs is labor-intensive and prone to sampling errors, potentially missing small metastases.
Purpose of the Study:
- To explore how molecular imaging can improve the accuracy of detecting lymph node metastases in prostate cancer.
- To demonstrate the complementary role of molecular imaging alongside traditional histopathology for nodal staging.
Main Methods:
- Utilizing radiolabeled prostate-specific membrane antigen (PSMA) ligands for image-guided surgery.
- Integrating molecular imaging data with histopathological analysis of surgical specimens.
Main Results:
- Molecular imaging provides new opportunities for enhanced pathological assessment of surgical specimens.
- This approach can complement histopathology for more accurate detection of LN metastases in prostate cancer.
Conclusions:
- Molecular imaging, particularly with PSMA ligands, shows promise for improving nodal staging in prostate cancer.
- Combining molecular imaging with histopathology can enhance the detection of lymph node metastases, leading to more accurate patient staging and treatment decisions.
